Cidara Therapeutics to Present at the 19th Annual Needham Virtual Healthcare Conference
Time: 2:50 PM ET
Webcast: A live audio webcast and replay of the presentation will be available in the
Investors section on the company’s website at www.cidara.com.
Cidara is developing therapeutics to improve the standard of care for patients facing severe fungal or viral infections. The Company’s portfolio is comprised of breakthrough approaches aimed at transforming existing treatment and prevention paradigms, first with its lead antifungal candidate, rezafungin, in addition to therapies targeting influenza and other viral diseases from Cidara’s proprietary Cloudbreak® platform. Cidara is headquartered in
Karen O’Shea, Ph.D.
Source: Cidara Therapeutics, Inc.